È«½ÂÀç ¸íÀÇ

õ¿¬¹°Áú Ȱ¿ëÇØ ·ù¸¶Æ¼½º Áúȯ, ôÃß°üÀý¿° Ä¡·á ÁÖ¸ñ

È«½ÂÀç ¸íÀÇ

  • ¼Ò ¼Ó
    °æÈñ´ëÇб³º´¿ø ·ù¸¶Æ¼½º³»°ú
  • Àü¹®ºÐ¾ß
    ·ù¸¶Æ¼½º °üÀý¿°, °­Á÷¼ºÃ´Ãß¿°, Åëdz, ·çǪ½º, Ç÷°ü¿°

±¹³»¿Ü ÇÐȸÁö¸¦ ÅëÇØ ¼ö¸¹Àº ¿¬±¸°á°ú¸¦ ¹ßÇ¥ÇÏ´Â ¿­Á¤ÀûÀÎ ÀÇ»ç´Ù.
ÁÖ¿ä Áø·á ºÐ¾ß´Â °üÀý¿°(·ù¸¶Æ¼½º, °­Á÷¼ºÃ´Ãß¿°, Åëdz, °ñ°üÀý¿°), ·çǪ½º ¹× Ç÷°ü¿°(·¹À̳ëÁõÈıº, º£Ã¼Æ®º´)ÀÌ´Ù. Ȳ¹é, Ȳ·Ã °°Àº ½Ä¹°ÀÇ ÃßÃâ¹°À» ÀÌ¿ëÇØ ·ù¸¶Æ¼½º Ȱ¸·¼¼Æ÷ÀÇ ±â´ÉÀ» ÁÙÀ̰ųª ¿°Áõ¹°ÁúÀ» Á¦°ÅÇÏ´Â Ä¡·á¹æ¹ýÀ» ±¹Á¦ ÇÐȸ¿¡ º¸°íÇØ ÇаèÀÇ °ü½ÉÀ» ²ø¾ú´Ù. »ý¹°ÇÐÀû Á¦Á¦, Ç¥ÀûÄ¡·áÁ¦¸¦ ÀÌ¿ëÇÑ ·ù¸¶Æ¼½º°üÀý¿°, °­Á÷ôÃß¿° Ä¡·á¿¡ Àϰ¡°ßÀÌ ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • °æÈñ´ëÇб³º´¿ø Àǰú´ëÇÐ Çлç
  • °æÈñ´ëÇб³º´¿ø Àǰú´ëÇÐ ¼®»ç
  • °æÈñ´ëÇб³º´¿ø Àǰú´ëÇÐ ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °æÈñ´ëÇб³º´¿ø ·ù¸¶Æ¼½º³»°ú Áø·á°úÀå
  • úÞ) °æÈñÀÇ·á¿ø Á¤º¸Àü·«½ÇÀå
  • úÞ) °æÈñ´ëÇб³º´¿ø ÀÇÇб³À°½ÇÀå
  • úÞ) °æÈñÀÇ·á¿ø ´ë¿ÜÇù·Âº»ºÎ ±¹Á¦±³·ù¼¾ÅÍ ºÎ¼¾ÅÍÀå
  • úÞ) °æÈñÀǰúÇבּ¸¿ø ¿¬±¸Áö¿ø°ü¸®½ÇÀå
  • úÞ) °æÈñ´ëÇб³º´¿ø ·ù¸¶Æ¼½ºÇб³½Ç ÁÖÀÓ±³¼ö
  • úÞ) °æÈñÀÇ·á¿ø °üÀý·ù¸¶Æ¼½º³»°ú ±³¼ö

¼ö»ó³»¿ª

Awards List
  • º¸°Çº¹ÁöºÎ Àå°ü ǥâ (2023)
  • ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ ¿ì¼ö°­»ç»ó (2019)

ÇÐȸȰµ¿

Academic activities
  • 2011 ~ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ º¸ÇèÀÌ»ç
  • 2012 ~ Çѱ¹ÀÇÇб³À°Æò°¡¿ø ÀÎÁõ±âÁØÀ§¿øÈ¸ À§¿ø
  • 2016 ~ ´ëÇѳëÀκ´ÇÐȸ Ãѹ«ÀÌ»ç
  • 2024 ~ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ Åëdz¿¬±¸È¸ ȸÀå
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Effect of abatacept versus conventional synthetic disease modifying anti-rheumatic drugs on rheumatoid arthritis-associated interstitial lung disease.
¹ßÇ¥³âµµ 2024.09 ¹ßÇ¥Áö Korean J Intern Med.
Á¦ ¸ñ Korean guidelines for the management of gout.
¹ßÇ¥³âµµ 2023.09 ¹ßÇ¥Áö Korean J Intern Med.
Á¦ ¸ñ Application of Salivary Alpha-1 Antitrypsin in the Diagnosis of Rheumatoid Arthritis: A Pilot Study.
¹ßÇ¥³âµµ 2024.04 ¹ßÇ¥Áö Medicina
Á¦ ¸ñ Antinociceptive and anti-inflammatory activity of DW-1021, the ionic complex of pelubiprofen and tramadol, in rodents.
¹ßÇ¥³âµµ 2023..07 ¹ßÇ¥Áö Biomed Pharmacother.
Á¦ ¸ñ Patient Perspectives and Preferences Regarding Gout and Gout Management: Impact on Adherence.
¹ßÇ¥³âµµ 2021.08 ¹ßÇ¥Áö J Korean Med Sci.
Á¦ ¸ñ The bone bridge significantly affects the decrease in bone mineral density measured with quantitative computed tomography in ankylosing spondylitis.
¹ßÇ¥³âµµ 2021.04 ¹ßÇ¥Áö PLoS One.
Á¦ ¸ñ Real-world experiences of the diagnosis process in Korean patients with ankylosing spondylitis based on a self-report questionnaire.
¹ßÇ¥³âµµ 2021.04 ¹ßÇ¥Áö J Int Med Res.

¸íÀÇqna ¸íÀÇ QnA

Q °¡Àå °ü½É ÀÖ´Â ºÐ¾ß¿Í ¾÷ÀûÀÌ ÀÖ´Ù¸é ¾Ë·ÁÁÖ¼¼¿ä

·ù¸¶Æ¼½º°üÀý¿°ÀÇ º´ÀÎ ¿¬±¸¿Í õ¿¬¹° ½Å¾à¿¡ ´ëÇÑ ¿¬±¸¸¦ ¼öÇàÇϰí ÀÖ´Ù.
´Ù¾çÇÑ ·ù¸¶Æ¼½º ÁúȯÀÇ »õ·Î¿î °Ë»ç¹ý°ú Ä¡·á ¾àÁ¦ÀÇ ÀûÀÀÁõ È®´ë, º¸Çè ±Þ¿© µîÀç¿Í ±Þ¿©±âÁØ È®´ë¸¦ À§ÇØ ³ë·ÂÇϰí ÀÖ´Ù.

Q ȯÀÚ Áø·á¿¡ ÀÖ¾î °¡Àå Áß¿äÇÏ°Ô »ý°¢ÇÏ´Â °¡Ä¡´Â?

·ù¸¶Æ¼½º ÁúȯÀÇ Á¤È®ÇÑ Áø´Ü°ú ÃÖÀûÀÇ Ä¡·á È¿°ú´Â ¹Ù·Î °íÅë¹Þ´Â ȯÀÚ ¾È¿¡ ÀÖ´Ù´Â ¹ÏÀ½À¸·Î ȯÀÚµéÀÇ ¸»°ú Çൿ ÇѰ¡Áö¶óµµ ³õÄ¡Áö ¾Êµµ·Ï ³ë·ÂÇϰí, Áúº´ ¿ÏÄ¡¸¦ À§ÇÑ ±ä ¿©Á¤¿¡ ȯÀÚ¿Í º¸È£ÀÚ, Àǻ簡 ÇÑ °¡Á·ÀÌ µÇ¾î ³¡±îÁö ÇÔ²² µ¿ÇàÇÏ´Â »îÀ» »ì°í ½Í´Ù.

Q ȯÀڵ鿡°Ô ÀüÇÏ°í ½ÍÀº ¸»¾¸

·ù¸¶Æ¼½º ÀÚ°¡¸é¿ªÁúȯÀº Àå±â°£ È£Àü°ú ¾ÇÈ­¸¦ ¹Ýº¹ÇÏ´Â ¸¸¼º ¿°ÁõÁúȯÀÌÁö¸¸, ÃÖ±Ù¿¡´Â ¿ÏÄ¡¿¡ µµÀüÇÏ´Â Çõ½ÅÀûÀÎ Ä¡·áÁ¦µéÀÌ ¸¹ÀÌ °³¹ßÀÌ µÇ¾î ¾ú½À´Ï´Ù.
Á¶±â Áø´Ü°ú Á¶±â Ä¡·áÀ» ÅëÇØ¼­ ¹«¼­¿î Áúº´ÀÇ °íÅë¿¡¼­ ¹þ¾î³ª ¾ó¸¶µçÁö Áñ°Ì°í ÇູÇÑ »îÀ» »ì ¼ö ÀÖÀ¸´Ï, º´¿¡ °É·È´Ù°í Àý¸ÁÇϰųª Æ÷±âÇÏÁö ¸¶½Ã°í Àû±ØÀûÀ¸·Î Ä¡·áÇÏ½Ã±æ ²À ´çºÎµå¸³´Ï´Ù.

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°æÈñ´ëÇб³º´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
02-958-8114
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°æÈñ´ëÇб³º´¿øÀº ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϸç, ±¹³» ÀÇ·á°è¸¦ ¼±µµÇÏ´Â »ó±ÞÁ¾ÇÕº´¿øÀÔ´Ï´Ù. ÃֽŠÀÇ·á ±â¼ú°ú Àåºñ¸¦ Ȱ¿ëÇÏ¿© ȯÀڵ鿡°Ô ÃÖ»óÀÇ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ÁßÁõÁúȯ Ä¡·á ¹× ¿¬±¸¿¡ °­Á¡À» º¸À̸ç, ´ÙÇÐÁ¦ ÇùÁø ½Ã½ºÅÛÀ» ÅëÇØ ȯÀÚÀÇ °Ç°­À» ÃÖ¿ì¼±À¸·Î »ý°¢ÇÕ´Ï´Ù. °æÈñ´ëÇб³º´¿øÀº ȯÀÚµéÀÇ ½Å·Ú¿Í ¸¸Á·µµ¸¦ ³ôÀÌ´Â µ¥ ÁÖ·ÂÇϸç, Áö¼ÓÀûÀ¸·Î ÀÇ·á ǰÁú Çâ»ó°ú ¿¬±¸ °³¹ß¿¡ Èû¾²°í ÀÖ½À´Ï´Ù.

°æÈñ´ëÇб³º´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã µ¿´ë¹®±¸ °æÈñ´ë·Î 23 °æÈñ´ëÇб³º´¿ø

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä